BioNexus Gene Lab Corp Common stock share price logo

BioNexus Gene Lab Corp Common stock Share Price

NASDAQ: BGLC

Small Cap

$2.20

+0.02

(+1.03%)

as on

BioNexus Gene Lab Corp Common stock Stock Performance

as on April 18, 2026 at 5:37 am IST

  • $2.20
    $2.20

  • 52 Week's Low

    52 Week's High

    $1.92
    $15.60
    downward going graph

    12.73%

    Downside

    609.09%

    Upside

    downward going graph

BioNexus Gene Lab Corp Common stock share price movements today

Previous Close
$2.18
Open
$2.20
Volume
163.8K
Day's Low - High
$2.20 - $2.20
52 Week Low - High
$1.92 - $15.60

BioNexus Gene Lab Corp Common stock Historical Returns

1 Month Return
-12.49 %
3 Month Return
-39.51 %
1 Year Return
-19.41 %
3 Year Return
-94.02 %
5 Year Return
0 %

BioNexus Gene Lab Corp Common stock Stock Fundamentals & Key Indicators

Check BioNexus Gene Lab Corp Common stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.3M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-35.24%

BioNexus Gene Lab Corp Common stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioNexus Gene Lab Corp Common stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BioNexus Gene Lab Corp Common stock image
BioNexus Gene Lab Corp Common stock
NA$5.3MNANA-40.20%
Ecolab Inc image
Ecolab Inc
HOLD$76.0B23.15%37.0312.91%
Sherwin-Williams Co image
Sherwin-Williams Co
BUY$85.6B29.46%33.6810.90%
Albemarle Corp image
Albemarle Corp
BUY$23.3B30.07%NA-9.93%
Air Products and Chemicals Inc image
Air Products and Chemicals Inc
BUY$65.0B1.51%NA-2.73%

Stock Returns calculator for BioNexus Gene Lab Corp Common stock Stock including INR - Dollar returns

The BioNexus Gene Lab Corp Common stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

BioNexus Gene Lab Corp Common stock investment value today

Current value as on today

₹87,549

Returns

-₹12,451

(-12.45%)

Returns from BioNexus Gene Lab Corp Common stock Stock

-₹19,414 (-19.41%)

Dollar Impact

₹6,963 (+6.96%)

BioNexus Gene Lab Corp Common stock Stock’s Investor Sentiment and Interest

Search interest for BioNexus Gene Lab Corp Common stock Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-4% versus previous 30 day period

BioNexus Gene Lab Corp Common stock Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
2
2
2
2
1
2
2
2
2
2
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
0
-2
0
0
0
-1
0
0
0
0
EBITDA
0
-2
-
0
0
-1
-
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-2
0
0
0
-1
0
0
0
0
Income Tax Expense
0
0
-
0
0
0
-
0
-
-
Net Income
0
-2
0
0
0
-1
0
0
0
0
Net Profit Margin
-10.10%
-102.17%
13.52%
-4.36%
10.08%
-51.15%
-13.80%
-29.17%
-27.26%
-27.87%

BioNexus Gene Lab Corp Common stock Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
0
0
11
13
10
9
9
Gross Profit
0
0
0
1
2
1
1
1
Operating Income
0
0
0
1
1
0
-2
-1
EBITDA
0
0
0
1
1
0
-2
-1
Interest Expense
-
-
-
0
0
0
0
0
Depreciation
-
0
0
0
0
0
0
0
Income Before Tax
0
0
0
1
1
0
-2
-1
Income Tax Expense
0
0
0
0
0
0
0
0
Net Income
0
0
0
1
0
0
-2
-1
Net Profit Margin
-114.92%
12.46%
-194.14%
9.61%
5.62%
-3.26%
-26.91%
-16.81%

BioNexus Gene Lab Corp Common stock Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
0
0
-1
0
0
0
0
-1
-1
Operating Cash Flow
0
0
-1
0
0
0
-1
0
0
Investing Cash Flow
0
0
0
-
0
0
0
-
0
Financing Cash Flow
0
0
0
0
0
0
0
0
0
Change in Cash
0
0
-1
0
0
0
0
1
-

BioNexus Gene Lab Corp Common stock Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
0
1
0
0
-2
-1
-2
Operating Cash Flow
0
0
0
0
0
0
-1
-2
-1
Investing Cash Flow
-5
0
0
1
0
0
-1
0
0
Financing Cash Flow
5
0
0
0
0
0
6
0
0
Change in Cash
0
0
0
1
0
0
3
-1
0

Insights on BioNexus Gene Lab Corp Common stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 2.13M → 2.54M (in $), with an average increase of 8.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Albemarle Corporation has given 307.5% return, outperforming this stock by 327.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Ecolab Inc. has given 5.0% return, outperforming this stock by 99.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, BGLC stock has moved down by -13.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -616.17K → -708.99K (in $), with an average decrease of 15.1% per quarter

About BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It also develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
OrganisationBioNexus Gene Lab Corp Common stock
HeadquartersMenara UOA Bangsar, Kuala Lumpur, Malaysia, 59000
IndustrySpecialty Chemicals
CEOMs. Set Fui Chong
E-voting on sharesClick here to vote

Key Management of BioNexus Gene Lab Corp Common stock

Name

Title

Ms. Set Fui Chong

Chief Financial Officer

Mr. Kwan Wah Chan

Marketing Manager

Mr. Too Kam Tham

Managing Director

FAQs

What is BioNexus Gene Lab Corp Common stock share price today?

BioNexus Gene Lab Corp Common stock share price today is $2.2 as on at the close of the market. BioNexus Gene Lab Corp Common stock share today touched a day high of $2.2 and a low of $2.2.

What is the 52 week high and 52 week low for BioNexus Gene Lab Corp Common stock share?

BioNexus Gene Lab Corp Common stock share touched a 52 week high of $15.6 on and a 52 week low of $1.92 on . BioNexus Gene Lab Corp Common stock stock price today i.e. is closed at $2.2,which is 85.90% down from its 52 week high and 14.58% up from its 52 week low.

What is BioNexus Gene Lab Corp Common stock's market capitalisation today?

BioNexus Gene Lab Corp Common stock market capitalisation is $0.00T as on .

How to invest in BioNexus Gene Lab Corp Common stock Stock (BGLC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BioNexus Gene Lab Corp Common stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BioNexus Gene Lab Corp Common stock Shares that will get you 0.6818 shares as per BioNexus Gene Lab Corp Common stock share price of $2.2 per share as on April 18, 2026 at 12:07 am IST.

What is the minimum amount required to buy BioNexus Gene Lab Corp Common stock Stock (BGLC) from India?

Indian investors can start investing in BioNexus Gene Lab Corp Common stock (BGLC) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in BioNexus Gene Lab Corp Common stock stock (as per the Rupee-Dollar exchange rate as on ). Based on BioNexus Gene Lab Corp Common stock share’s latest price of $2.2 as on April 18, 2026 at 12:07 am IST, you will get 4.5455 shares of BioNexus Gene Lab Corp Common stock. Learn more about fractional shares .